Transparent Thinking Blog
This week in transparency news: February 12-26, 2021
The EU Clinical Trial Regulation obliges clinical trial sponsors to submit the result of their drug trials to the Clinical Trials Information System (CTIS), a new European trial registry due to be launched in late 2021.
This week in transparency news: January 30 – February 12, 2021
Read the latest transparency news in the pharma, biotech, and medical device industries from January 30 – February 12, 2021.
This week in transparency news: January 9 – January 29, 2021
Review news of transparency, disclosure, data sharing, and communication in clinical trials for the weeks of January 9-29, 2021.
This week in transparency news: December 19, 2020 – January 8, 2021
Read the latest clinical trial disclosure and data transparency news from December 19, 2020 – January 8, 2021.
Lay Summary Whitepaper
Start drafting plain language summaries (lay summaries) now or get left behind. Dowload this free resources to learn more.
This week in transparency news: December 5 – December 18, 2020
News from the pharmaceutical industry on clinical data sharing, trial transparency, and disclosures for the weeks of Dec. 5-18, 2020.
This week in transparency news: November 21 – December 4, 2020
This week in transparency news features clinical trial disclosure and data transparency news from November 21 – December 4, 2020. Read now!
This week in transparency news: November 7 – November 20, 2020
Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. Select recent and relevant stories from November 7-20, 2020 are included.
This week in transparency news: May 30 – June 12, 2020
Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. Select recent and relevant stories are as follows:
FDA Furthers Transparency Push with CSR Release Pilot
The FDA provided insight into their overall vision for clinical trial transparency last week, announcing a new program to publicly release clinical study reports (CSRs) that accompany drug approval submissions. They plan to pilot nine recently-approved drugs (yet to be determined) from volunteer sponsors, with CSRs to be posted to the FDA’s drug approval database, Drugs@FDA.
6880 Commerce Blvd.
Canton, MI 48187
+1 734 738 5100
